Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,970.00
Bid: 1,968.00
Ask: 1,970.00
Change: -30.00 (-1.50%)
Spread: 2.00 (0.102%)
Open: 2,008.00
High: 2,012.00
Low: 1,958.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: UK Equities Firm Ahead Of Central Bank Meetings

Thu, 05th Sep 2013 09:56

LONDON (Alliance News) - London's main equity markets all trade modestly higher by mid morning Thursday with the FTSE 100 up just 0.2% at 6,488 points. The FTSE 250 is 0.5% higher, while the AIM All-Share is 0.1% higher.

European markets opened with positivity taken from Asia, where markets have closed higher after the Bank of Japan revised up its assessment of the economy but kept liquidity high, with its monetary easing program unchanged. The FTSE 100, CAC 40 and DAX all opened strongly, each rising about 0.5% but have slid slightly by mid morning with the European majors now about flat on the day.

Traders seem less concerned this morning by the ongoing debate over military intervention in Syria over its alleged use of chemical weapons. US President Barack Obama secured backing from a Senate committee late on Wednesday for a limited strike on the country, but will now have to get through a full House and Senate vote which will wait until next week.

Following Wednesday's profit warning from Ryanair that sent all airline stocks tumbling, most are rebounding strongly Thursday after the release of August traffic statistics from easyJet that showed an increase in passenger numbers of 3.9% over the month. EasyJet shares trade 1.56% higher, and International Consolidated Airlines Group trade 2% higher.

At the other end of the spectrum, pharmaceuticals are amongst the biggest fallers as GSK released disappointing results of tests of a new melanoma treatment drug. GSK is one of the biggest blue-chip fallers, down 1.5%. Hikma is down 0.9% and Shire down 0.3%.

Another positive economic reading for the UK has come in the form of new car sales, which have increased for the 18th month in a row and are now above pre-recession levels. The data is helping the pound to maintain Wednesday's break above 1.56 against the dollar, currently trading at USD1.5615.

Big events still to come are central bank meetings.

The BoE's decisions on interest rates and asset purchasing are due at mid-day. No change is expected, and there is no mandatory statement. With every economic indicator of late coming out strongly, Governor Mark Carney may prefer to remain quiet Thursday. However if any statement is released it will be watched with keen interest as to how Carney will further defend his forward guidance.

Also, at 1245 BST, the ECB will announce interest rates. Again, no change expected but Governor Mario Draghi will be giving his usual press conference.

By Jon Darby; jondarby@alliancenews.com; @jondarby100

Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
27 Aug 2021 12:32

Hikma, Bio-Thera enter exclusive agreement for monoclonal antibody

(Sharecast News) - Bio-Thera Solutions and Hikma Pharmaceuticals have entered into a commercialisation and license agreement to commercialise a monoclonal antibody used for the treatment of Crohn's disease.

Read more
20 Aug 2021 09:46

LONDON BROKER RATINGS: Peel Hunt ups InterContinental Hotels to Hold

LONDON BROKER RATINGS: Peel Hunt ups InterContinental Hotels to Hold

Read more
20 Aug 2021 08:10

LONDON BRIEFING: Softbank's Fortress doesn't give up on Morrisons

LONDON BRIEFING: Softbank's Fortress doesn't give up on Morrisons

Read more
17 Aug 2021 09:46

UPDATE 2-Energy, healthcare stocks lift FTSE 100; BHP Group shines

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* UK employment closer to pre-pandemic levels* BHP Group jumps on strong results* PLUS500 gains on robust revenue forecasts* FTSE 100 up 0.3%...

Read more
12 Aug 2021 16:04

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
6 Aug 2021 17:06

LONDON MARKET CLOSE: FTSE 100 boosted by strong US jobs report

LONDON MARKET CLOSE: FTSE 100 boosted by strong US jobs report

Read more
6 Aug 2021 12:07

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

Read more
6 Aug 2021 09:03

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

Read more
6 Aug 2021 08:40

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

Read more
6 Aug 2021 07:42

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

Read more
6 Aug 2021 07:22

Hikma lifts FY generics guidance as first-half profits, revenue jump

(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance for its generics arm and reported a rise in first-half profit and revenue as it hailed a strong performance in both the generics and branded segments, and resilience in the injectables business.

Read more
30 Jul 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
14 Jul 2021 19:38

IN BRIEF: Arecor ends first half of 2021 with solid cash position

IN BRIEF: Arecor ends first half of 2021 with solid cash position

Read more
13 Jul 2021 10:00

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

Read more
1 Jul 2021 09:51

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.